GEBEXO Trademark

Trademark Overview


On Friday, August 31, 2012, a trademark application was filed for GEBEXO with the United States Patent and Trademark Office. The USPTO has given the GEBEXO trademark a serial number of 79118138. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, August 31, 2022. This trademark is owned by Novartis AG. The GEBEXO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
gebexo

General Information


Serial Number79118138
Word MarkGEBEXO
Filing DateFriday, August 31, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, August 31, 2022
Registration Number4287433
Registration DateTuesday, February 12, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, March 27, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, July 17, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 16, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, June 15, 2020INVALIDATION PROCESSED
Wednesday, May 13, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 13, 2019CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Sunday, April 28, 2013NOTIFICATION PROCESSED BY IB
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 15, 2013FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 15, 2013FINAL DISPOSITION PROCESSED
Thursday, March 14, 2013GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 12, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Monday, November 26, 2012NOTIFICATION PROCESSED BY IB
Wednesday, November 7, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2012NOTICE OF PUBLICATION
Monday, October 22, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 22, 2012ASSIGNED TO EXAMINER
Tuesday, October 16, 2012APPLICATION FILING RECEIPT MAILED
Friday, October 12, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 11, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords


gebexo human vaccines